On the morning of March 19, 2026, the National Healthcare Security Administration held an introduction activity on the adjustments to the Diagnosis-Related Group (DRG) Payment Scheme 3.0. In July 2024, the National Healthcare Security Administration issued the 2.0 version of the Diagnosis-Related Group (DRG) Payment Scheme, which introduced adjustments and optimizations to the 1.0 version released in 2020. In August 2025, the National Healthcare Security Administration formulated the "Interim Measures for the Management of Disease-Based Payment in Medical Security," stipulating that the disease classification scheme should be adjusted in principle every two years. Huang Xinyu, Director of the Pharmaceutical Management Department of the National Healthcare Security Administration, stated that the adjustment to the grouping scheme is primarily based on four key factors: real-world healthcare settlement data from recent years, extensive feedback from various stakeholders, advancements in medical technology, and the requirements of healthcare policy and management. Regarding the adjustment of main content. Focusing on clinical opinions with concentrated consensus on influencing factors such as age, comorbidities, and complications, targeted improvements were made to subgrouping rules, including age subgroups, unilateral/bilateral/multiple-site surgeries, obstetric subgroups, radiotherapy/chemotherapy for malignant tumors, and combined surgeries. The DRG primarily adjusted core groupings and subgroups, while the DIP mainly adjusted the core disease catalog. The adjustment work is expected to publicly release the 3.0 version grouping plan around July this year, with the official implementation planned for January 2027.